AJMC - Change is Coming

AJMC - Change is Coming

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|April 4, 2025

Addressing Resource and Bandwidth Challenges in Bispecific Antibody Administration

Experts discuss how institutions can address the resource and bandwidth challenges that come with administering complex therapies like bispecifics.

Episodes in this series

EP. 1 Expanding Horizons: The Present and Future of Bispecific Antibodies Across Oncology

EP. 1 Expanding Horizons: The Present and Future of Bispecific Antibodies Across Oncology

3 experts are featured in this series.

EP. 2 Revolutionizing Cancer Treatment: Key Bispecific Antibody Approvals

3 experts are featured in this series.

EP. 3 How Bispecific Antibodies Are Reshaping Cancer Care

3 experts are featured in this series.

EP. 4 Optimizing Bispecific Antibody Use: Opportunities to Broaden Patient Access

3 experts are featured in this series.

EP. 5 Integrating Bispecific Antibodies in Community Oncology: Benefits and Considerations

3 experts are featured in this series.

EP. 6 Overcoming Key Operational Challenges in Integrating Bispecific Therapies

3 experts are featured in this series.

EP. 7 Partnerships in Bispecific Therapy: A Model for Supporting Community Oncology

3 experts are featured in this series.

EP. 8 Managing Complexity: Standardizing Workflows for Multiple Bispecific Therapies

3 experts are featured in this series.

EP. 9 Standardizing CRS Management and Ensuring Smooth Transitions of Care in Bispecific Therapy

3 experts are featured in this series.

EP. 10 Optimizing Bispecific Antibody Administration With EHR and Technology Solutions

3 experts are featured in this series.

EP. 11 Addressing Resource and Bandwidth Challenges in Bispecific Antibody Administration

3 experts are featured in this series.

EP. 12 Payer and Reimbursement Considerations for Bispecific Therapies

3 experts are featured in this series.

EP. 13 Emerging Therapeutic Areas for Bispecific Antibodies

3 experts are featured in this series.

EP. 14 Incorporating Bispecific Antibodies Earlier in Treatment and Improving Access in Underserved Communities

3 experts are featured in this series.

EP. 15 Future Breakthroughs: What’s Next for Bispecific Antibodies in Oncology?

Video content above is prompted by the following:

How can institutions address the resource and bandwidth challenges that come with administering complex therapies like bispecifics?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Global connection concept-S-stock.adobe.com.jpeg

Photobiomodulation, Bio-Machines, and the Future of Dermatology

ByGiuliana Grossi

January 30th 2026

Addressing the Fragmentation of MS Care: Kavita Nair, PhD

ByKavita V. Nair, PhD

January 30th 2026

Glaucoma awareness month | Image credit: khaled - stock.adobe.com

Glaucoma Awareness Month Shines Light on Eye Condition Known as the Silent Thief

ByJulia Bonavitacola,Jullia Rosdahl, MD, PhD,Ariana Levin, MD,Manjool Shah, MD

January 30th 2026

Image credit: Yurii Kibalnik-stock.adobe.com

Combination Therapy, Biologics, and Surgery Redefine HS Care in 2026

ByGiuliana Grossi

January 29th 2026

Manjool Shah, MD

Treatment for Glaucoma Continues to Evolve, Allowing Eye Doctors to Personalize Treatment: Manjool Shah, MD

ByJulia Bonavitacola,Manjool Shah, MD

January 29th 2026

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Trending on AJMC

AI-Supported Mammography Caught More Cancers During Screening

Combination Therapy, Biologics, and Surgery Redefine HS Care in 2026

The Strategic Necessity of Pharma-MedTech Convergence in an Era of Precision Medicine

CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.